Demand Drivers in the Market GLP-1 treatment requires repeated decisions after the first prescription
Wed, Jul 22, 2026 0 Comments Audio By Carbonatix By Nancy Lapid July 22 (Reuters) The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest
In eczema skin, even trace endotoxin contamination could trigger flares
Combined with L-Carnitine, a nutrient that transports stored fat into cells to be burned for energy, patients receive both appetite control and enhanced metabolic support
The amounts of different antioxidant components like GSH, AsA, carotenoids, phenols, proline, and glycine betaine also changed in response to salt stress
Surprisingly, most rodent studies to date have focused on events that occur following a single dose of Glp1r agonists